INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Most active filers · 30d

  1. 01Kurtz George0B / 217S · 10 late217 trades$54.77M
  2. 02SPSaba Capital Management, L.P.55B / 19S · 3 late74 trades$23.87M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04CFCheng Chi Fung0B / 42S42 trades$15.33M
  5. 05RARothblatt Martine A0B / 33S33 trades$5.50M
  6. 06RJRubinstein Julie0B / 32S32 trades$5.55M
  7. 07LBLeach Bryan0B / 30S30 trades$7.97M
  8. 08AOAtay Oguzhan0B / 30S30 trades$7.55M
  9. 09JDJenkins William D Jr0B / 30S30 trades$13.38M
  10. 10BSBiswas Sanjit0B / 28S28 trades$22.33M

Form 4 transactions

65,929 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
BH
Boodakian Stephen HarryDirector
WSBKWinchester Bancorp, Inc./MD/
Grant or award
A$41K
3,000 sh
Nov 4, 2026Nov 6, 2026
Page 18 of 1649
← PrevNext →
traded Nov 4, 2026
+2d
SEC Form 4

Evidence

9
HJ
Harte Neal JosephDirector
WSBKWinchester Bancorp, Inc./MD/
Grant or award
A$41K
3,000 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

9
BD
Bergwerk DovInterim Cheif Legal Officer
TEVATEVA PHARMACEUTICAL INDUSTRIES LTD
Option exercise
M—
8,755 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

9
SM
Sabag MarkSee "Remarks"
TEVATEVA PHARMACEUTICAL INDUSTRIES LTD
Option exercise
M—
46.0K sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

9
MG
McMahon Lisa GDirector
WNEBWestern New England Bancorp, Inc.
Grant or award
A$3,468
247 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

9
MD
Masse William DDirector
WNEBWestern New England Bancorp, Inc.
Grant or award
A$4,577
326 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

9
RJ
Russo Joseph J.EVP&Pres-Global Networks&Tech
VZVERIZON COMMUNICATIONS INC
Grant or award
A$1,104
84 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

9
DJ
Damon Donna J.Director
WNEBWestern New England Bancorp, Inc.
Grant or award
A$4,043
288 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

9
CC
Cantwell Wayne CDirector
AIPArteris, Inc.
Option exercise
M$3,000
5,000 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

9
FP
Foster Jonathan P.Chief Financial Officer
MBRXMoleculin Biotech, Inc.
Option exercise
M—
41 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

9
FG
Fitzgerald Gary GDirector
WNEBWestern New England Bancorp, Inc.
Grant or award
A$4,535
323 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

9
SH
Schulman Daniel HDirector, CEO
VZVERIZON COMMUNICATIONS INC
Grant or award
A$2,661
202 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

9
KA
Kiewiet Stephen A.Chief Operating Officer
TCMDTACTILE SYSTEMS TECHNOLOGY INC
Grant or award
A—
6,438 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

9
WD
Wood William David IIIChief Financial Officer
AGYSAGILYSYS INC
Grant or award
A—
5,143 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

9
RJ
Robertson Chris JController
AGYSAGILYSYS INC
Grant or award
A—
922 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

9
BC
Badger Kyle CSVP, GC and Secretary
AGYSAGILYSYS INC
Grant or award
A—
3,099 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

9
FM
Foster Jon MEVP and COO
HCAHCA Healthcare, Inc.
Option exercise
M—
35.9K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

9
RV
Rockett Julie ValsaVP, Chief People Officer
MSMMSC INDUSTRIAL DIRECT CO INC
Tax withholding
F$3,903
34 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

9
SK
Shacklett KimberlySVP, Customer Experience
MSMMSC INDUSTRIAL DIRECT CO INC
Option exercise
M—
621 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

9
MH
Machek HowardChief Accounting Officer
CENTCENTRAL GARDEN & PET CO
Option exercise
M—
4,968 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

9
SS
Shivashankar SethuramCTO
AGYSAGILYSYS INC
Grant or award
A—
4,848 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

9
HR
Humphrey RachelDirector
PYXSPyxis Oncology, Inc.
Grant or award
A—
34.5K sh
Nov 6, 2026Nov 6, 2026
traded Nov 6, 2026
+0dSEC Form 4

Evidence

9
AY
Abdelrahman Joe Ahmed YoussefChief Commercial Officer
AGYSAGILYSYS INC
Grant or award
A—
2,789 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

9
SS
Sakhamuri SivakesavaChief Technical Officer
CRSPCRISPR Therapeutics AG
Grant or award
A—
40.0K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

9
SS
Sakhamuri SivakesavaChief Technical Officer
CRSPCRISPR Therapeutics AG
Grant or award
A—
90.0K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

9
SK
Shacklett KimberlySVP, Customer Experience
MSMMSC INDUSTRIAL DIRECT CO INC
Option exercise
M—
417 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

9
SS
Schaefer Scott StephenChief Financial Officer
HLFHERBALIFE LTD.
Grant or award
A—
3,391 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

9
LA
Love Scott AEVP - Wealth Management
WSBCWESBANCO INC
Option exercise
M—
1,500 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

9
KV
Klemp Walter VDirector, CEO and President
MBRXMoleculin Biotech, Inc.
Option exercise
M—
57 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

9
QM
Quenzer MichaelEVP, Chief Financial Officer
LIILENNOX INTERNATIONAL INC
Option exercise
M—
635 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

9
FP
Foster Jonathan P.Chief Financial Officer
MBRXMoleculin Biotech, Inc.
Tax withholding
F$84.6
10 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

9
HP
Hill Jesse P.Chief Financial Officer
AGNTAGNT, Inc.
Tax withholding
F$2,104
538 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

9
HJ
Hazlin JohnChief Growth Officer
CLCOLGATE PALMOLIVE CO
Option exercise
M—
23.4K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

9
TP
Tsourapas PanagiotisCOO, CD, EMEA, APac, Skin
CLCOLGATE PALMOLIVE CO
Option exercise
M—
19.9K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

9
BJ
Beraud JillDirector
LEVILEVI STRAUSS & CO
Grant or award
A—
97 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

9
SD
Swayze DanielChief Operating Officer
BWMNBowman Consulting Group Ltd.
Disposition to issuer
D—
62.8K sh
Nov 6, 2026Nov 6, 2026
traded Nov 6, 2026
+0dSEC Form 4

Evidence

9
PE
Prime Joshua EDirector
LEVILEVI STRAUSS & CO
Grant or award
A—
111 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

9
ES
Eisenhardt Shannon SDirector
UPSUNITED PARCEL SERVICE INC
Grant or award
A—
918 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

9
JJ
Jackson JamereCFO
AZOAUTOZONE INC
Option exercise
M—
6,900 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

9
BD
Buonasera DavidCHIEF TECHNOLOGY OFFICER
MGNIMAGNITE, INC.
Open-market sale · 10b5-1 plan
SELL$115K
4,272 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  3. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  4. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  5. SELLIBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
  6. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
  7. BUYBBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K
  8. SELLBCYCBICYCLE THERAPEUTICS PLCOct 2 – Oct 56 insiders$63K